Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/11/2008US7449333 Methods and compositions for tissue regeneration
11/11/2008US7449321 Controlling a flavivirus entry into a cell by administering to the cell an agent functionally interfering with a flavivirus receptor protein, the flavivirus receptor protein being an integrin
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/11/2008US7449311 Fermenting macedocin for use as bacteriocin in packaged, canned and ready to eat foods; prevention of food spoilage
11/11/2008US7449302 ligands isolated from Moraxella catarrhalis outer membrane protein which binds to carcinoembryonic antigen cell adhesion molecules (CEACAM) receptors, and inhibits bacterial adhesion to CEACAM expressing cells in vitro; drugs and vaccines used in the treatment or prophylaxis of infections
11/11/2008US7449201 Storage stable power compositions of interleukin-4 receptor
11/11/2008US7449200 positively charged shell substrate, negatively charged core substrate with encapsulated bioactive agents; for projectile bombardment; composed of chitosan/poly-glutamic acid/insulin or chitosan/poly-glutamic acid/pDNA for transcutaneous delivery
11/11/2008US7449192 Therapy for bladder infections
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/11/2008US7449182 Using vascular endothelial growth factor specific immunoglobulin as tool in diagnosis, prevention and treatment of cell proliferative, respiratory, vision and inflammatory disorders
11/11/2008US7449177 administering to gamma-interferon, in combination with antihistamines, antiallergens, corticosteroids or mixtures, for the treatment of autoimmune skin diseases; suppression of chemotaxis and function of eosinophils
11/11/2008US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors
11/11/2008US7448379 Composition, vessel, dry powder inhalation system, and related methods for transpulmonary administration
11/11/2008CA2588369A1 Methods of treatment and prevention of metabolic bone diseases and disorders
11/11/2008CA2588361A1 Methods of treatment and prevention of neurodegenerative diseases and disorders
11/06/2008WO2008134759A2 Treatment of myeloproliferative disorders with adaptor protein lnk
11/06/2008WO2008134752A2 Methods and compositions for the treatment of cancer
11/06/2008WO2008134721A1 Methods for administering anti-il-5 antibodies
11/06/2008WO2008134644A1 High viscosity macromolecular compositions for treating ocular conditions
11/06/2008WO2008134635A1 Heparin binding epidermal growth factor (hb-egf) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation
11/06/2008WO2008134544A1 Compositions for prevention of adhesions and other barrier applications
11/06/2008WO2008134528A1 Anti-cancer agent-hyaluronic acid conjugate compositions and methods
11/06/2008WO2008134524A2 Compositions and methods for regulating t-cell activity
11/06/2008WO2008134464A2 Sample-processing reagent compositions, methods, and devices
11/06/2008WO2008134432A1 Proteinase inhibitors and uses thereof
11/06/2008WO2008134429A1 Cysteine proteinase inhibitors and uses thereof
11/06/2008WO2008134425A1 Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
11/06/2008WO2008134406A1 Ischemia-induced neovascularization is enhanced by hcns-sc transplantation
11/06/2008WO2008134398A1 Oximyl dipeptide hepatitis c protease inhibitors
11/06/2008WO2008134397A1 Aza-tripeptide hepatitis c serine protease inhibitors
11/06/2008WO2008134310A1 Stabilization of liquid solutions of recombinant protein for frozen storage
11/06/2008WO2008134124A1 Ul97 inhibitors for treatment of proliferative disorders
11/06/2008WO2008134123A1 Ul97 for treatment of protein aggregate disorders
11/06/2008WO2008134020A1 Ccl18 and ccl3 methods and compositions for detecting and treating cancer
11/06/2008WO2008133961A2 Igf-1r binding proteins and antagonists
11/06/2008WO2008133928A2 Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
11/06/2008WO2008133908A2 Suspension formulations of insulinotropic peptides and uses thereof
11/06/2008WO2008133886A1 Methods and compositions for promoting localization of pharmaceutically active agents to bone
11/06/2008WO2008133759A2 Antiviral peptides
11/06/2008WO2008133651A2 Ablative immunotherapy
11/06/2008WO2008133618A1 Methods and compositions for fostering and preserving bone growth
11/06/2008WO2008133597A1 Method of delivering a protein into a cell
11/06/2008WO2008133546A1 Method for producing an antitumoral vaccine based on surface endothelial cell antigens
11/06/2008WO2008133511A2 Modified phosphatases
11/06/2008WO2008133501A1 Good tasting food product containing an agent for reducing carbohydrate uptake; and compositions containing such an agent
11/06/2008WO2008133349A1 Agent for prevention of cirrhosis/precancerous lesion comprising natriuretic peptide as active ingredient
11/06/2008WO2008133225A1 Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis
11/06/2008WO2008133208A1 Method for enhancing immune response with peptide
11/06/2008WO2008133141A1 Osmotin recombinant protein, method for production of the same, and use of the same
11/06/2008WO2008133137A1 Vector for gene therapy
11/06/2008WO2008133036A1 Method for screening of therapeutic agent for renal tubular dysfunction
11/06/2008WO2008132737A1 Novel antimicrobial agents
11/06/2008WO2008132732A2 Methods and compositions for rectal administration of proteins
11/06/2008WO2008132731A2 Methods and compositions for rectal administration of insulin
11/06/2008WO2008132712A2 Combination pharmaceutical compositions
11/06/2008WO2008132709A1 Products for altering il-33 activity and methods therefor
11/06/2008WO2008132568A2 Fusion proteins binding to growth factors
11/06/2008WO2008132516A1 Toll-like receptor binding epitope and compositions for binding thereto
11/06/2008WO2008132485A2 Mutants of interleukin- 1 receptor antagonist and uses thereof
11/06/2008WO2008132477A1 Compounds and uses thereof
11/06/2008WO2008132435A1 Y-receptor agonists
11/06/2008WO2008132264A1 Citrulinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
11/06/2008WO2008132229A2 Highly concentrated insulin solutions and compositions
11/06/2008WO2008132224A2 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
11/06/2008WO2008132175A1 A method for detecting the binding between mdm2 and the proteasome
11/06/2008WO2008132155A2 Inhibitors of the binding between hdm2 and the proteasome
11/06/2008WO2008132153A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/06/2008WO2008131941A1 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation
11/06/2008WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/06/2008WO2008131599A1 T-cell receptor vaccines materials and methods
11/06/2008WO2008115548A3 Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
11/06/2008WO2008106507A3 Mdm2/mdmx inhibitor peptide
11/06/2008WO2008106151A3 Co-crystals and pharmaceutical compositions comprising the same
11/06/2008WO2008105835A3 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
11/06/2008WO2008101121A3 Methods and compositions relating to promoter regulation by muc1 and klf proteins
11/06/2008WO2008100567A3 Thrombin peptide derivatives for treating fractures in osteopenic patients
11/06/2008WO2008100556A3 Alimentary protein-based scaffolds (aps) for wound healing, regenerative medicine and drug discovery
11/06/2008WO2008095015A3 Method of treating recurrent tumors
11/06/2008WO2008094708A3 Activin-actriia antagonists and uses for treating or preventing breast cancer
11/06/2008WO2008091911A3 Use of antibody conjugates
11/06/2008WO2008091682A3 Soluble fc gamma r1a for reducing inflammation
11/06/2008WO2008088846A3 Substance p and analogs thereof as an immunogenic composition adjuvant
11/06/2008WO2008088403A3 Method of purifying apolipoprotein a-1
11/06/2008WO2008086006A3 Sp35 antibodies and uses thereof
11/06/2008WO2008085900A3 Methods for generating novel stabilized proteins
11/06/2008WO2008083228A3 Compositions and methods for treating inflammation and auto-immune diseases
11/06/2008WO2008080093A3 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
11/06/2008WO2008079685A3 Lipase variants for pharmaceutical use
11/06/2008WO2008076824A3 Therapeutic and diagnostic peptides
11/06/2008WO2008076370A3 P21 compositions and methods for the treatment of hiv
11/06/2008WO2008073984A3 Nmdar biomarkers for diagnosing and treating cerebral ischemia
11/06/2008WO2008073395A3 Compositions and methods for cardiac tissue protection and regeneration
11/06/2008WO2008073174A3 Antimicrobial therapy
11/06/2008WO2008070538A3 Micellar nanoparticles comprising botulinum toxin
11/06/2008WO2008067305A3 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain
11/06/2008WO2008063650A3 Systems of hydrogen and formic acid production in yeast
11/06/2008WO2008061011A3 Intra-vascular kidney gene therapy with plasmid encoding bmp-7
11/06/2008WO2008060811A3 Peptides facilitating or inhibiting anterograde transport
11/06/2008WO2008048373A3 Compounds and methods for modulating protein degradation
11/06/2008WO2008039994A3 Targeted photodynamic therapy agent
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 3163